Quick Answer
Cell Source, Inc. reported Operating Income Loss of -$4.33 million for the year ending 2023.
- Cell Source, Inc. showed a decrease of -3.6% in Operating Income Loss from 2022 to 2023.
- This data is from Cell Source, Inc.'s annual report (Form 10-K), filed with the SEC on June 24, 2024.
- XBRL data for this metric is available from 2017 to 2023 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$772.7 thousand | Q2 2014: -$1.02 million | Q3 2014: -$715.3 thousand | Q1 2015: -$587.7 thousand | Q2 2015: -$567.7 thousand | Q3 2015: -$549.1 thousand | Q1 2016: -$644.7 thousand | Q2 2016: -$530.2 thousand | Q3 2016: -$601.7 thousand | Q1 2017: -$483.6 thousand | Q2 2017: -$646.6 thousand | Q3 2017: -$555.1 thousand | Q1 2018: -$660.1 thousand | Q2 2018: -$423.9 thousand | Q3 2018: -$488.6 thousand | Q1 2019: -$1.17 million | Q2 2019: -$708.7 thousand | Q3 2019: -$1.36 million | Q1 2020: -$733.3 thousand | Q2 2020: -$903.3 thousand | Q3 2020: -$1.17 million | Q1 2021: -$1.12 million | Q2 2021: -$995.1 thousand | Q3 2021: -$1.32 million | Q1 2022: -$1.05 million | Q2 2022: -$1.03 million | Q3 2022: -$1.02 million | Q1 2023: -$1.42 million | Q2 2023: -$905.5 thousand | Q3 2023: -$995.4 thousand | Q1 2024: -$1.14 million | Q2 2024: -$1.19 million | Q3 2024: -$831.6 thousand.
- Over the full 7 years of available data (2017 to 2023), Cell Source, Inc.'s Operating Income Loss has declined by 88.6%.
- Historical annual values: Fiscal year 2023: -$4.33 million | Fiscal year 2022: -$4.18 million | Fiscal year 2021: -$4.02 million | Fiscal year 2020: -$3.64 million | Fiscal year 2019: -$3.81 million | Fiscal year 2018: -$2.01 million | Fiscal year 2017: -$2.29 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: